CSTL

CSTL EBITDA Margin

-0.91%TTM

Period ending:

CSTL FY EBITDA Margin%
CSTL FY EBITDA Margin31.27%-87.06%
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CSTL ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Castle Biosciences Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
3.2952%
11.485%
-20.4852%
-42.5747%
-38.9052%
-11.3234%
19.8168%
-16.5083%
-75.6104%

Compare ebitda margin

All CSTL financial metrics · CSTL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.